If you are wondering whether Amgen's current share price still offers value after a strong run, this article walks through ...

In the closing of the recent trading day, Amgen (AMGN) stood at $330.05, denoting a -3.39% move from the preceding trading day.

Eli Lilly is riding the wave of a booming weight management market. Eli Lilly's tirzepatide, sold under the brand names ...

In the closing of the recent trading day, Amgen (AMGN) stood at $320.71, denoting a -2.12% move from the preceding trading day.

Amgen acquires Dark Blue Therapeutics for up to $840 million, adding early-stage leukemia drug research and strengthening its oncology discovery pipeline.

Zenas BioPharma shares fall after Phase 3 obexelimab data in IgG4-RD showed a 56% flare risk reduction, as investors weigh ...

No or a negative gap between dividend yield and free cash flow yield defines a cash-poor stock. That is, their dividend ...

There is an even more important question to address.

As of Wednesday, January 07, Arrowhead Pharmaceuticals, Inc.’s ARWR share price has dipped by 7.85%, which has investors questioning if this is right time to buy.

The Dow Jones Industrial Average itself yields modestly, but the Dogs of the Dow 2026 pack more dividend bite.

A phase 3 study of Zenas BioPharma's autoimmune disease candidate has hit its primary endpoint. But, with the result falling ...